BioCentury | Dec 8, 2014
Emerging Company Profile
CRISPR-based therapies
Caribou Biosciences Inc. and Atlas Venture co-founded Intellia Therapeutics LLC to develop gene and cell therapies based on Caribou's CRISPR genome editing technology. Intellia has exclusive rights to CRISPR IP from a co-inventor of the...